These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6104337)

  • 1. Labetalol blockade of central alpha- and beta-noradrenergic receptors in rat brain homogenates.
    Devoto P; Stefanini E; Marchisio AM; Vernaleone F; Collu R
    Pharmacol Res Commun; 1980 Feb; 12(2):177-82. PubMed ID: 6104337
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of labetalol and YM-09538 on neuronal uptake of (3H)norepinephrine in the rat vas deferens.
    Cohen ML; Hynes LM
    Clin Exp Hypertens A; 1983; 5(4):563-75. PubMed ID: 6133660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.
    Aggerbeck M; Guellaen G; Hanoune J
    Br J Pharmacol; 1978 Apr; 62(4):543-8. PubMed ID: 26446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha- and beta-adrenoceptor blockade by labetalol in human isolated arteries and veins.
    Thulesius O; Gjöres JE; Berlin E
    Br J Clin Pharmacol; 1980 Jun; 9(6):621-3. PubMed ID: 6104500
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacology of labetalol, an alpha- and beta-adrenoceptor blocking agent.
    Blakeley AG; Summers RJ
    Gen Pharmacol; 1978; 9(6):399-402. PubMed ID: 32121
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-adrenergic receptor-linked adenylate cyclase in rat posterior pituitary.
    Stefanini E; Marchisio AM; Vernaleone F; Devoto P; Collu R
    Life Sci; 1980 Feb; 26(8):589-94. PubMed ID: 6247595
    [No Abstract]   [Full Text] [Related]  

  • 7. beta-Adrenergic sensitive adenylate cyclase in rat posterior pituitary.
    Vernaleone F; Devoto P; Marchisio AM; Stefanini E; Spano PF
    Pharmacol Res Commun; 1980 Apr; 12(4):359-63. PubMed ID: 6248902
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interaction of labetalol with alpha- and beta-adrenergic receptors : biochemical study (author's transl)].
    Dausse JP; Guicheney P; Maich PJ; Meyer P
    Nouv Presse Med; 1978 Oct; 7(35):3121-3. PubMed ID: 31601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha- and beta-blocking activities of racemates of labetalol.
    Nakagawa Y; Shimamoto N; Nakazawa M; Imai S
    Jpn J Pharmacol; 1980 Oct; 30(5):743-5. PubMed ID: 6110798
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.
    Monopoli A; Bamonte F; Forlani A; Ongini E; Parravicini L
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):256-63. PubMed ID: 6151824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
    Richards DA; Tuckman J; Prichard BN
    Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of labetalol on the circulatory system (author's transl)].
    Monma Y; Okuoka Y; Kameda H; Ichihara K; Abiko Y; Tanabe T
    Nihon Yakurigaku Zasshi; 1980 May; 76(4):239-54. PubMed ID: 6108907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing.
    Govoni S; Spano PF; Trabucchi M
    J Pharm Pharmacol; 1978 Jul; 30(7):448-9. PubMed ID: 27613
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
    Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
    J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some complementary data on AH 5158, an inhibitor of both alpha-and beta-adrenoceptors [proceedings].
    Harichaux P; Hary L
    Br J Pharmacol; 1976 Nov; 58(3):412P. PubMed ID: 11020
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues.
    Brittain RT; Drew GM; Levy GP
    Br J Pharmacol; 1982 Sep; 77(1):105-14. PubMed ID: 6127131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain.
    Quik M; Iversen LL
    Eur J Pharmacol; 1979 Jul; 56(4):323-30. PubMed ID: 477728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.